User login
Researchers at the University of Miami in Florida and University of Cyprus have each been awarded $100,000 to explore two drug repurposing projects to identify possible treatments for Alport syndrome. The funding was provided by the Alport Syndrome Foundation, Pedersen Family, and the Kidney Foundation of Canada.
Alport syndrome is a genetic condition characterized by kidney disease, hearing loss and eye abnormalities. When the Alport Syndrome Foundation was established in 2007, there was little funding or interest in researching this rare condition. In recent years, partly as a result of the foundation’s support for research and development of basic resources to assist researchers, several potential new treatments have entered the pipeline and are in development. Read more about this and the recent funding awards on the foundation’s website.
Researchers at the University of Miami in Florida and University of Cyprus have each been awarded $100,000 to explore two drug repurposing projects to identify possible treatments for Alport syndrome. The funding was provided by the Alport Syndrome Foundation, Pedersen Family, and the Kidney Foundation of Canada.
Alport syndrome is a genetic condition characterized by kidney disease, hearing loss and eye abnormalities. When the Alport Syndrome Foundation was established in 2007, there was little funding or interest in researching this rare condition. In recent years, partly as a result of the foundation’s support for research and development of basic resources to assist researchers, several potential new treatments have entered the pipeline and are in development. Read more about this and the recent funding awards on the foundation’s website.
Researchers at the University of Miami in Florida and University of Cyprus have each been awarded $100,000 to explore two drug repurposing projects to identify possible treatments for Alport syndrome. The funding was provided by the Alport Syndrome Foundation, Pedersen Family, and the Kidney Foundation of Canada.
Alport syndrome is a genetic condition characterized by kidney disease, hearing loss and eye abnormalities. When the Alport Syndrome Foundation was established in 2007, there was little funding or interest in researching this rare condition. In recent years, partly as a result of the foundation’s support for research and development of basic resources to assist researchers, several potential new treatments have entered the pipeline and are in development. Read more about this and the recent funding awards on the foundation’s website.